Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBTB7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,871
Award facts
- Contract value 100% obligated
- $17,870.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,870.69 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Zepbound is a GLP-1 receptor agonist used for weight management in eligible patients, representing one of many specialized pharmaceutical products supplied through AmerisourceBergen's federal contracts. This delivery order exemplifies the company's role in supplying brand-name medications across multiple therapeutic domains to support military treatment facilities and other federal healthcare institutions. AmerisourceBergen's competitively awarded contracts and significant contract portfolio demonstrate its capability to meet federal procurement requirements efficiently through established IDC vehicles, which provide flexibility in delivering essential medical commodities to government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FBTB7?
SPE2DR26FBTB7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FBTB7 worth?
The government has obligated $17,871 on SPE2DR26FBTB7.
Is contract SPE2DR26FBTB7 an order under another contract?
Yes. SPE2DR26FBTB7 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBTB7 competed?
The extent of competition for SPE2DR26FBTB7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award